SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.19+0.6%Dec 19 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jerry Olson who wrote (2852)5/24/1998 6:56:00 PM
From: The Prophet  Read Replies (3) of 9523
 
It's funny how double-talk can pass for analysis. PFE is dramatically undervalued based on the present value of future growth. The FDA scare has fizzled. Viagra will sell $2 billion this year, and $5 billion next. That alone is worth $2 a share. Add in remaining earnings and new drugs and you have PFE at $5 to $6 a share earnings 1999. A decent growth multiple (like 30) for a premiere worldwide company, and you can see why, in all likelihood, PFE will trade up towards 150 in no time. Management may even change their minds and split in July. Don't miss the boat - there are few that sail this quickly.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext